Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
McKesson
Johnson and Johnson
Medtronic
Harvard Business School

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204300


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 204300 describes VAZCULEP, which is a drug marketed by Avadel Legacy and is included in one NDA. It is available from one supplier. Additional details are available on the VAZCULEP profile page.

The generic ingredient in VAZCULEP is phenylephrine hydrochloride. There are twenty-one drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride profile page.
Summary for 204300
Tradename:VAZCULEP
Applicant:Avadel Legacy
Ingredient:phenylephrine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 204300
Mechanism of ActionAdrenergic alpha1-Agonists
Suppliers and Packaging for NDA: 204300
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VAZCULEP phenylephrine hydrochloride SOLUTION;INTRAVENOUS 204300 NDA BluePoint Laboratories 68001-331 68001-331-65 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68001-331-65) > 10 mL in 1 VIAL, PHARMACY BULK PACKAGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength10MG/ML (10MG/ML)
Approval Date:Jun 27, 2014TE:AP1RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength50MG/5ML (10MG/ML)
Approval Date:Jun 27, 2014TE:AP1RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength100MG/10ML (10MG/ML)
Approval Date:Jun 27, 2014TE:AP1RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Baxter
McKesson
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.